Rising Expenditure In R&D Activities To Uplift The Cell-Based Assays Market

Jul-2020 | Others

The cell-based assay is described as a method of study of living cell based on different parameters. These assays are utilized to determine practically of biochemical or cellular functions. In these assays, functional cells are utilized as diagnostic means in the study of new drugs. Pharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations, government institutions, and others use the cell-based assays. They assist in evaluating cell proliferation, morphology toxicity, motility, production of an assessable product in drug discovery and diagnostics.

Cell-based assays enable exploration in the field of immunology, cancer, stem cells, and others. The growth of the cell-based assays market is impelled by the rising expenditures in drug discovery, speedy technological improvements, augmented implementation of high-throughput screening techniques, the progress in the automation as well as non-invasive systems of monitoring, and boost in activities related to the cell-based research.

Moreover, the rise in accessibility of sponsors for innovation & R&D and progress in drug delivery activity has driven the market growth. Additionally, the rise in espousal of label-free cell-based assays and the unexploited budding countries present beneficial prospects for development of the cell-based assays market. Furthermore, noteworthy benefits of cell-based assay, need to decrease prices linked with drug discovery, and improvements in technological advanced products are anticipated to fuel the market growth.

Apart from this, the other factors such as government support for the R&D activities, the incidence of several chronic diseases, and enhancing healthcare infrastructure are also expected to drive the market growth. Moreover, the surfacing of new technologies such as improved detection technologies, 3D cell-based assays, the wide application range of cell-based assays, and rising need for toxicity screening are likely to present new opportunities for the market growth.

On the other hand, the high operational & on maintenance rates, standardization & accuracy concerns, shortage of experienced staff who can control the technology, and strict intellectual property rights that confines technological innovations are few of the factors that can hamper the growth of the cell-based assays market.